{"id":529668,"date":"2021-08-19T08:03:38","date_gmt":"2021-08-19T12:03:38","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointment-of-michael-inbar-cpa-mba-as-senior-vice-president-finance\/"},"modified":"2021-08-19T08:03:38","modified_gmt":"2021-08-19T12:03:38","slug":"solid-biosciences-announces-appointment-of-michael-inbar-cpa-mba-as-senior-vice-president-finance","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointment-of-michael-inbar-cpa-mba-as-senior-vice-president-finance\/","title":{"rendered":"Solid Biosciences Announces Appointment of Michael Inbar, CPA, MBA, as Senior Vice President, Finance"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">CAMBRIDGE, Mass., Aug.  19, 2021  (GLOBE NEWSWIRE) &#8212; Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), today announced that Michael Inbar, CPA, MBA, has joined the Company as Senior Vice President, Finance, effective August 16, 2021.<\/p>\n<p align=\"justify\">Mr. Inbar brings to Solid an extensive background in public accounting, with expertise in building finance teams, designing financial processes, and implementing new systems. Most recently, he served as VP, Accounting and Corporate Controller at Syros Pharmaceuticals, Inc., a clinical stage biopharmaceutical company specializing in the discovery and development of medicines to treat rare diseases and cancer, where he was responsible for all aspects of the accounting and finance operations. Prior to that, he served as Chief Financial Officer and VP, Finance at Acronis, Inc., where he led the global finance team and IT business systems, and Acceleron Pharma Inc., where he was Associate Director of SEC Reporting.<\/p>\n<p align=\"justify\">\u201cMichael brings valuable experience to Solid as we continue to grow and evolve as a company,\u201d said Ilan Ganot, Co-Founder, President and Chief Executive Officer of Solid Biosciences. \u201cRealizing our multiple opportunities to improve patients\u2019 lives requires continued financial discipline and diverse capabilities, and we welcome Michael\u2019s expertise in this important aspect of our operations.\u201d<\/p>\n<p align=\"justify\">Mr. Inbar received his Master\u2019s in Business Administration and Bachelor of Business Administration &amp; Accounting from the College of Business Management, Israel. He also received his Public Accountant certification in Israel and in the United States.<\/p>\n<p align=\"justify\">\u201cMy prior experience in rare disease drug development has given me a profound appreciation of the challenges that patients with these diseases face, and I believe that Solid has significant potential to improve the lives of patients,\u201d said Mr. Inbar. \u201cI am excited for the opportunity to be part of the team working to transform that potential into meaningful therapies.\u201d<\/p>\n<p align=\"justify\">\n        <strong>About Solid Biosciences<\/strong><br \/>\n        <br \/>Solid Biosciences is a life sciences company focused on advancing transformative treatments to improve the lives of patients living with Duchenne. Disease-focused and founded by a family directly impacted by Duchenne, our mandate is simple yet comprehensive \u2013 work to address the disease at its core by correcting the underlying mutation that causes Duchenne with our lead gene therapy candidate, SGT-001. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PQIVl5T4WmvWMg9LjuHHUqIQnrtz4jDob36dYbTiRXNk1HDq95BHtiQJVzonKJoBW8HxuEDAe1Uo6cEAhkgnNQ==\" rel=\"nofollow noopener\" target=\"_blank\">www.solidbio.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>David Carey<br \/>FINN Partners<br \/>212-867-1768<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=O02vcgYHERC1hcfNp38ky8HAepDLbSwHOokF8_AP-JQWGQblJSinwjrzHAs9ml9yiyIlyvdmoD3DsLBGnjS5hERQCVcsik4HX_u8BNcfSBsUHxpxiiSnyPdJyG4vTNq6\" rel=\"nofollow noopener\" target=\"_blank\">David.Carey@finnpartners.com<\/a><\/p>\n<p>Caitlin Lowie<br \/>Solid Biosciences <br \/>607-423-3219<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EmcSZnHEksqW0E27GyUJyZawl-25Sd3kScocleWqYv0RxdywNj9GeHcC7ZcvLv-Pazks0bl0uQ7Yqz-f_EX51cx8YLTeWiDS46vXsxe90ZA=\" rel=\"nofollow noopener\" target=\"_blank\">Clowie@solidbio.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Erich Sandoval<br \/>FINN Partners<br \/>917-497-2867<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Xvoxo3lb1ytxft11gK6ByMnOseVN-dmJFheMT-TQahR-yYKsM-RAiE-a5WHrnUunmV-kP7wrv1iztZW0BPGMMC-DVpNLebEPuHUeytPfeoduXsG4daEmsawZveawY07u\" rel=\"nofollow noopener\" target=\"_blank\">Erich.Sandoval@finnpartners.com<\/a>\u00a0<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxMTgxMSM0MzY1NzY5IzIwOTExOTc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NjVmZDJhZWMtZjE1Yi00MjIyLThkNzMtNjg2ZTM1Mjk1N2MzLTExMDI3Njg=\/tiny\/Solid-Biosciences-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE, Mass., Aug. 19, 2021 (GLOBE NEWSWIRE) &#8212; Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), today announced that Michael Inbar, CPA, MBA, has joined the Company as Senior Vice President, Finance, effective August 16, 2021. Mr. Inbar brings to Solid an extensive background in public accounting, with expertise in building finance teams, designing financial processes, and implementing new systems. Most recently, he served as VP, Accounting and Corporate Controller at Syros Pharmaceuticals, Inc., a clinical stage biopharmaceutical company specializing in the discovery and development of medicines to treat rare diseases and cancer, where he was responsible for all aspects of the accounting and finance operations. Prior to that, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointment-of-michael-inbar-cpa-mba-as-senior-vice-president-finance\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Solid Biosciences Announces Appointment of Michael Inbar, CPA, MBA, as Senior Vice President, Finance&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-529668","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Solid Biosciences Announces Appointment of Michael Inbar, CPA, MBA, as Senior Vice President, Finance - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointment-of-michael-inbar-cpa-mba-as-senior-vice-president-finance\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Solid Biosciences Announces Appointment of Michael Inbar, CPA, MBA, as Senior Vice President, Finance - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass., Aug. 19, 2021 (GLOBE NEWSWIRE) &#8212; Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), today announced that Michael Inbar, CPA, MBA, has joined the Company as Senior Vice President, Finance, effective August 16, 2021. Mr. Inbar brings to Solid an extensive background in public accounting, with expertise in building finance teams, designing financial processes, and implementing new systems. Most recently, he served as VP, Accounting and Corporate Controller at Syros Pharmaceuticals, Inc., a clinical stage biopharmaceutical company specializing in the discovery and development of medicines to treat rare diseases and cancer, where he was responsible for all aspects of the accounting and finance operations. Prior to that, &hellip; Continue reading &quot;Solid Biosciences Announces Appointment of Michael Inbar, CPA, MBA, as Senior Vice President, Finance&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointment-of-michael-inbar-cpa-mba-as-senior-vice-president-finance\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-19T12:03:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxMTgxMSM0MzY1NzY5IzIwOTExOTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-announces-appointment-of-michael-inbar-cpa-mba-as-senior-vice-president-finance\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-announces-appointment-of-michael-inbar-cpa-mba-as-senior-vice-president-finance\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Solid Biosciences Announces Appointment of Michael Inbar, CPA, MBA, as Senior Vice President, Finance\",\"datePublished\":\"2021-08-19T12:03:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-announces-appointment-of-michael-inbar-cpa-mba-as-senior-vice-president-finance\\\/\"},\"wordCount\":419,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-announces-appointment-of-michael-inbar-cpa-mba-as-senior-vice-president-finance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxMTgxMSM0MzY1NzY5IzIwOTExOTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-announces-appointment-of-michael-inbar-cpa-mba-as-senior-vice-president-finance\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-announces-appointment-of-michael-inbar-cpa-mba-as-senior-vice-president-finance\\\/\",\"name\":\"Solid Biosciences Announces Appointment of Michael Inbar, CPA, MBA, as Senior Vice President, Finance - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-announces-appointment-of-michael-inbar-cpa-mba-as-senior-vice-president-finance\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-announces-appointment-of-michael-inbar-cpa-mba-as-senior-vice-president-finance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxMTgxMSM0MzY1NzY5IzIwOTExOTc=\",\"datePublished\":\"2021-08-19T12:03:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-announces-appointment-of-michael-inbar-cpa-mba-as-senior-vice-president-finance\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-announces-appointment-of-michael-inbar-cpa-mba-as-senior-vice-president-finance\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-announces-appointment-of-michael-inbar-cpa-mba-as-senior-vice-president-finance\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxMTgxMSM0MzY1NzY5IzIwOTExOTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxMTgxMSM0MzY1NzY5IzIwOTExOTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-announces-appointment-of-michael-inbar-cpa-mba-as-senior-vice-president-finance\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Solid Biosciences Announces Appointment of Michael Inbar, CPA, MBA, as Senior Vice President, Finance\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Solid Biosciences Announces Appointment of Michael Inbar, CPA, MBA, as Senior Vice President, Finance - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointment-of-michael-inbar-cpa-mba-as-senior-vice-president-finance\/","og_locale":"en_US","og_type":"article","og_title":"Solid Biosciences Announces Appointment of Michael Inbar, CPA, MBA, as Senior Vice President, Finance - Market Newsdesk","og_description":"CAMBRIDGE, Mass., Aug. 19, 2021 (GLOBE NEWSWIRE) &#8212; Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), today announced that Michael Inbar, CPA, MBA, has joined the Company as Senior Vice President, Finance, effective August 16, 2021. Mr. Inbar brings to Solid an extensive background in public accounting, with expertise in building finance teams, designing financial processes, and implementing new systems. Most recently, he served as VP, Accounting and Corporate Controller at Syros Pharmaceuticals, Inc., a clinical stage biopharmaceutical company specializing in the discovery and development of medicines to treat rare diseases and cancer, where he was responsible for all aspects of the accounting and finance operations. Prior to that, &hellip; Continue reading \"Solid Biosciences Announces Appointment of Michael Inbar, CPA, MBA, as Senior Vice President, Finance\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointment-of-michael-inbar-cpa-mba-as-senior-vice-president-finance\/","og_site_name":"Market Newsdesk","article_published_time":"2021-08-19T12:03:38+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxMTgxMSM0MzY1NzY5IzIwOTExOTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointment-of-michael-inbar-cpa-mba-as-senior-vice-president-finance\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointment-of-michael-inbar-cpa-mba-as-senior-vice-president-finance\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Solid Biosciences Announces Appointment of Michael Inbar, CPA, MBA, as Senior Vice President, Finance","datePublished":"2021-08-19T12:03:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointment-of-michael-inbar-cpa-mba-as-senior-vice-president-finance\/"},"wordCount":419,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointment-of-michael-inbar-cpa-mba-as-senior-vice-president-finance\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxMTgxMSM0MzY1NzY5IzIwOTExOTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointment-of-michael-inbar-cpa-mba-as-senior-vice-president-finance\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointment-of-michael-inbar-cpa-mba-as-senior-vice-president-finance\/","name":"Solid Biosciences Announces Appointment of Michael Inbar, CPA, MBA, as Senior Vice President, Finance - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointment-of-michael-inbar-cpa-mba-as-senior-vice-president-finance\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointment-of-michael-inbar-cpa-mba-as-senior-vice-president-finance\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxMTgxMSM0MzY1NzY5IzIwOTExOTc=","datePublished":"2021-08-19T12:03:38+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointment-of-michael-inbar-cpa-mba-as-senior-vice-president-finance\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointment-of-michael-inbar-cpa-mba-as-senior-vice-president-finance\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointment-of-michael-inbar-cpa-mba-as-senior-vice-president-finance\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxMTgxMSM0MzY1NzY5IzIwOTExOTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxMTgxMSM0MzY1NzY5IzIwOTExOTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-announces-appointment-of-michael-inbar-cpa-mba-as-senior-vice-president-finance\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Solid Biosciences Announces Appointment of Michael Inbar, CPA, MBA, as Senior Vice President, Finance"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/529668","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=529668"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/529668\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=529668"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=529668"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=529668"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}